Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
2.440
-0.050 (-2.01%)
At close: Apr 15, 2026, 4:00 PM EDT
2.520
+0.080 (3.28%)
Pre-market: Apr 16, 2026, 6:07 AM EDT
Moleculin Biotech Market Cap
Moleculin Biotech has a market cap or net worth of $13.02 million as of April 16, 2026. Its market cap has decreased by -10.82% in one year.
Market Cap
13.02M
Enterprise Value
4.50M
1-Year Change
-10.82%
Ranking
Category
Stock Price
$2.44
Market Cap Chart
Since June 2, 2016, Moleculin Biotech's market cap has decreased from $70.70M to $13.02M, a decrease of -81.58%. That is a compound annual growth rate of -15.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 13.30M | 98.51% |
| Dec 31, 2025 | 6.70M | 31.37% |
| Dec 31, 2024 | 5.10M | -80.08% |
| Dec 29, 2023 | 25.60M | -15.51% |
| Dec 30, 2022 | 30.30M | -43.05% |
| Dec 31, 2021 | 53.20M | 6.83% |
| Dec 31, 2020 | 49.80M | 19.14% |
| Dec 31, 2019 | 41.80M | 48.23% |
| Dec 31, 2018 | 28.20M | -28.24% |
| Dec 29, 2017 | 39.30M | 42.91% |
| Dec 30, 2016 | 27.50M | -61.10% |
| Jun 2, 2016 | 70.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IN8bio | 13.79M |
| Intensity Therapeutics | 13.46M |
| Hoth Therapeutics | 13.33M |
| BioCardia | 13.02M |
| Cellectar Biosciences | 12.89M |
| Kairos Pharma | 12.85M |
| Cyclerion Therapeutics | 12.81M |
| Imunon | 12.36M |